Citius Oncology Inc.CTORNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+28.2%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+28.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.1x
Strong expansion
Streak
4 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$25.53M+8.6%
2025$23.52M+14.3%
2024$20.57M+69.7%
2023$12.12M+24.8%
2022$9.71M-